Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw bought 21,142 shares of the stock in a transaction dated Wednesday, October 23rd. The stock was purchased at an average cost of $0.74 per share, with a total value of $15,645.08. Following the completion of the purchase, the chief executive officer now directly owns 14,794,794 shares in the company, valued at approximately $10,948,147.56. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.
Retractable Technologies Stock Performance
RVP stock traded down $0.02 during midday trading on Thursday, reaching $0.72. The company’s stock had a trading volume of 79,461 shares, compared to its average volume of 88,255. The business’s 50-day simple moving average is $0.85 and its 200-day simple moving average is $1.00. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54. Retractable Technologies, Inc. has a 52 week low of $0.71 and a 52 week high of $1.34.
Retractable Technologies (NYSE:RVP – Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The company had revenue of $6.03 million during the quarter.
Institutional Trading of Retractable Technologies
Analyst Ratings Changes
Separately, StockNews.com began coverage on Retractable Technologies in a report on Friday, October 18th. They issued a “hold” rating on the stock.
Check Out Our Latest Research Report on Retractable Technologies
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Recommended Stories
- Five stocks we like better than Retractable Technologies
- Which Wall Street Analysts are the Most Accurate?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What is a Special Dividend?
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.